PLASMA PROTEIN THERAPEUTICS ASSOCIATION for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 18, 2017 | $50,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Dec 14, 2017 | $120,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Health Issues HCR
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.